We are live on ! Find out more
Bender Robert & Associates

Bender Robert & Associates Portfolio holdings

AUM $525M Turnover 26.53%
1-Year Est. Return 38.43%
This Fund
S&P 500
This Quarter Est. Return
+3.04%
1 Year Est. Return
+38.43%
3 Year Est. Return
+145.82%
5 Year Est. Return
+189.35%
10 Year Est. Return
+1,046.87%
AUM
$168M
AUM Growth
-$3.01M
Cap. Flow
-$3.31M
Cap. Flow %
-1.96%
Top 10 Hldgs %
59.32%
Holding
59
New
3
Increased
22
Reduced
24
Closed
4
Avg Time Held
1.7 years
Top 10 Avg Time Held
1.4 years
Top 20 Avg Time Held
1.5 years

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$4.36M
2
PRLB icon
Protolabs
PRLB
+$2.39M
3
META icon
Meta Platforms (Facebook)
META
+$1.72M
4
CAT icon
Caterpillar
CAT
+$205K
5
KMI icon
Kinder Morgan
KMI
+$115K

Top Sells

Rank Stock Value
1
PCYC
PHARMACYCLICS INC
PCYC
+$7.11M
2
NDLS icon
Noodles & Co
NDLS
+$1.18M
3
POWI icon
Power Integrations
POWI
+$1.17M
4
WOLF icon
Wolfspeed
WOLF
+$814K
5
CTSH icon
Cognizant
CTSH
+$663K

Sector Composition

Rank Sector Weight
1 Healthcare 38.69%
2 Technology 23.8%
3 Consumer Discretionary 20.19%
4 Communication Services 8.85%
5 Miscellaneous 2.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
AAPL icon
1
Apple
AAPL
$5.02T
$20.4M 12.08%
648,988
-4,096
-0.6% -$131K
2013 Q2
8 quarters
ILMN icon
2
Illumina
ILMN
$31.4B
$14.2M 8.44%
66,909
-963
-1% -$188K
2013 Q2
8 quarters
GILD icon
3
Gilead Sciences
GILD
$208B
$12.6M 7.49%
107,793
-777
-0.7% -$84.9K
2013 Q2
8 quarters
CELG
4
DELISTED
Celgene Corp
CELG
$11.4M 6.79%
98,838
-2,173
-2% -$248K
2013 Q2
8 quarters
CTSH icon
5
Cognizant
CTSH
$29.7B
$8.32M 4.94%
136,184
-10,555
-7% -$663K
2013 Q2
8 quarters
ISRG icon
6
Intuitive Surgical
ISRG
$166B
$7.62M 4.52%
141,462
-342
-0.2% -$19.1K
2013 Q2
8 quarters
ALXN
7
DELISTED
Alexion Pharmaceuticals
ALXN
$6.67M 3.96%
36,909
+191
+0.5% +$33K
2013 Q2
8 quarters
LULU icon
8
lululemon athletica
LULU
$12.9B
$6.62M 3.93%
101,416
-257
-0.3% -$16.7K
2013 Q2
8 quarters
CAVM
9
DELISTED
Cavium, Inc.
CAVM
$6.21M 3.69%
90,288
-906
-1% -$63.5K
2013 Q2
8 quarters
GOOG icon
10
Alphabet (Google) Class C
GOOG
$3.46T
$5.88M 3.49%
222,020
-21,948
-9% -$588K
2013 Q2
8 quarters
META icon
11
Meta Platforms (Facebook)
META
$1.55T
$5.32M 3.16%
62,094
+21,009
+51% +$1.72M
2015 Q1
1 quarter
ULTA icon
12
Ulta Beauty
ULTA
$27.8B
$5.18M 3.08%
33,555
-138
-0.4% -$21.2K
2013 Q2
8 quarters
VIPS icon
13
Vipshop
VIPS
$6.64B
$5.05M 3%
226,990
-360
-0.2% -$9.5K
2014 Q1
5 quarters
VMW
14
DELISTED
VMware, Inc
VMW
$4.87M 2.89%
56,805
-965
-2% -$84.2K
2013 Q2
8 quarters
BIIB icon
15
Biogen
BIIB
$36.1B
$4.5M 2.67%
11,132
+86
+0.8% +$34.5K
2015 Q1
1 quarter
ABBV icon
16
AbbVie
ABBV
$509B
$4.49M 2.66%
+66,810
New +$4.36M
2015 Q2
0 quarters
SBUX icon
17
Starbucks
SBUX
$121B
$4.37M 2.59%
81,488
-152
-0.2% -$7.71K
2013 Q2
8 quarters
AMZN icon
18
Amazon
AMZN
$2.81T
$4.2M 2.49%
193,500
-1,580
-0.8% -$33K
2013 Q2
8 quarters
MELI icon
19
Mercado Libre
MELI
$77.6B
$3.45M 2.05%
24,355
+58
+0.2% +$8.21K
2013 Q2
8 quarters
BKNG icon
20
Booking.com
BKNG
$127B
$3.33M 1.98%
72,300
+1,500
+2% +$71.6K
2013 Q2
8 quarters
MDVN
21
DELISTED
MEDIVATION, INC.
MDVN
$3.18M 1.89%
55,684
+1,516
+3% +$93.5K
2014 Q1
5 quarters
BIDU icon
22
Baidu
BIDU
$27.1B
$2.98M 1.77%
14,968
+122
+0.8% +$25K
2013 Q2
8 quarters
PRLB icon
23
Protolabs
PRLB
$1.5B
$2.28M 1.35%
+33,803
New +$2.39M
2015 Q2
0 quarters
KMI icon
24
Kinder Morgan
KMI
$67.3B
$2.25M 1.33%
58,568
+2,758
+5% +$115K
2013 Q3
7 quarters
TFM
25
DELISTED
THE FRESH MARKET, INC COM STK
TFM
$1.57M 0.93%
48,825
-738
-1% -$25.8K
2013 Q2
8 quarters
1
2 3

Similar funds

A
Alongside Austin, Texas $525M AUM
Decagon Asset Management
Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return
DAFNA Capital Management
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
49 Wealth Management
49 Wealth Management Austin, Texas $524M AUM 16.59% 1-Year Est. Return
Schwarz Dygos Wheeler Investment Advisors
Schwarz Dygos Wheeler Investment Advisors Minneapolis, Minnesota $524M AUM 25.1% 1-Year Est. Return
Stieven Capital Advisors
Stieven Capital Advisors St. Louis, Missouri $524M AUM 29.72% 1-Year Est. Return
West Michigan Advisors
West Michigan Advisors Holland, Michigan $526M AUM 45.54% 1-Year Est. Return
Unio Capital
Unio Capital Princeton, New Jersey $526M AUM 25.9% 1-Year Est. Return

Bender Robert & Associates's Q2 2015 Portfolio in Review

As of Q2 2015, Bender Robert & Associates held 59 positions worth $168M, down 1.8% from $171M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Bender Robert & Associates's Q2 2015 filing shows 3 new, 22 increased, 24 reduced and 4 closed positions. Its largest new stake was AbbVie: 66,810 shares worth $4.49M. The largest sale was PHARMACYCLICS INC, an estimated $7.11M.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, up from 33% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Bender Robert & Associates's largest Q2 2015 buy was AbbVie: 66,810 shares worth $4.49M.
  • Bender Robert & Associates added most to Meta Platforms (Facebook) in Q2 2015, an estimated $1.72M increase.
  • Bender Robert & Associates's biggest Q2 2015 reduction was Cognizant, cutting an estimated $663K.
  • Bender Robert & Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $7.11M.
  • Bender Robert & Associates's ten largest holdings make up 59% of its $168M portfolio in Q2 2015.
  • Bender Robert & Associates opened 3 new positions and closed 4 in Q2 2015.
  • Bender Robert & Associates's portfolio value fell 1.8% quarter-over-quarter to $168M.

Based on Bender Robert & Associates's 13F filing for Q2 2015, filed 10 Aug 2015.